Document Type
Article
Publication Date
11-2026
Identifier
DOI: 10.1038/s41431-026-02195-7; PMCID: PMC13743746
Abstract
Variants in BRSK2, encoding brain specific kinase-2, have recently been associated with an autosomal dominant neurodevelopmental disorder (NDD). We have assembled 52 cases with heterozygous BRSK2 variants and variable neurodevelopmental phenotypes with frequent neuropsychiatric and behavioral symptoms. The variant spectrum included 15 different truncating variants, seven (potential) splice variants, three structural variants, and 12 different missense variants. Of the missense variants, seven were in the kinase domain, and the others in the UBA and the KA1 domain or outside domains. Variants occurred de novo in 19 cases and were inherited in 18. We utilized Drosophila melanogaster as a model and assessed viability and performed climbing and bang sensitivity assays upon knockdown of the fly orthologue sff or upon overexpression of wildtype or mutant human BRSK2. Pan-neuronal knockdown of sff resulted in impaired locomotor behavior and seizure susceptibility. Ubiquitous or pan-neuronal overexpression of human wildtype BRSK2 in Drosophila resulted in lethality or locomotor impairment, respectively, indicating toxicity. Overexpressing mutant BRSK2 did not or incompletely affect viability and locomotor behavior for six of seven tested kinase domain missense variants and one KA1 domain variant, indicating a (partial) loss-of-function effect. Interestingly, overexpressing BRSK2 with the remaining missense variant from the kinase domain and the two most C-terminal missense variants resulted in possible gain of function. Our findings further delineate the clinical and molecular spectrum of BRSK2-associated NDD and provide further insights into the role of BRSK2/sff in nervous system function and dysfunction.
Journal Title
European journal of human genetics : EJHG
Volume
34
Issue
11
First Page
1644
Last Page
1653
MeSH Keywords
Animals; Humans; Drosophila melanogaster; Neurodevelopmental Disorders; Protein Serine-Threonine Kinases; Female; Male; Mutation, Missense; Phenotype; Drosophila Proteins
PubMed ID
42509346
Keywords
Animals; Humans; Drosophila melanogaster; Neurodevelopmental Disorders; Protein Serine-Threonine Kinases; Female; Male; Mutation, Missense; Phenotype; Drosophila Proteins
Recommended Citation
Singhal P, Hsieh TC, Ehmke N, et al. Further characterization of the BRSK2-associated neurodevelopmental disorder. Eur J Hum Genet. 2026;34(11):1644-1653. doi:10.1038/s41431-026-02195-7


Comments
Grants and funding
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Link: https://www.nature.com/articles/s41431-026-02195-7